These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1998451)

  • 1. Evaluation of treatment protocols on minimal to moderate spasticity in multiple sclerosis.
    Brar SP; Smith MB; Nelson LM; Franklin GM; Cobble ND
    Arch Phys Med Rehabil; 1991 Mar; 72(3):186-9. PubMed ID: 1998451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
    Wissel J; Entner T
    Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tizanidine treatment of spasticity: a meta-analysis of controlled, double-blind, comparative studies with baclofen and diazepam.
    Groves L; Shellenberger MK; Davis CS
    Adv Ther; 1998; 15(4):241-51. PubMed ID: 10186943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vibration therapy in multiple sclerosis: a pilot study exploring its effects on tone, muscle force, sensation and functional performance.
    Schyns F; Paul L; Finlay K; Ferguson C; Noble E
    Clin Rehabil; 2009 Sep; 23(9):771-81. PubMed ID: 19561035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early physiotherapy after injection of botulinum toxin increases the beneficial effects on spasticity in patients with multiple sclerosis.
    Giovannelli M; Borriello G; Castri P; Prosperini L; Pozzilli C
    Clin Rehabil; 2007 Apr; 21(4):331-7. PubMed ID: 17613573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electromyographic response to manual passive stretch of the hemiplegic wrist: accuracy, reliability, and correlation with clinical spasticity assessment and function.
    Sorinola IO; White CM; Rushton DN; Newham DJ
    Neurorehabil Neural Repair; 2009; 23(3):287-94. PubMed ID: 19050174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind comparative trial of new muscle relaxant, tizanidine (DS 103-282), and baclofen in the treatment of chronic spasticity in multiple sclerosis.
    Smolenski C; Muff S; Smolenski-Kautz S
    Curr Med Res Opin; 1981; 7(6):374-83. PubMed ID: 7016449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of hydrotherapy for the management of spasticity.
    Kesiktas N; Paker N; Erdogan N; Gülsen G; Biçki D; Yilmaz H
    Neurorehabil Neural Repair; 2004 Dec; 18(4):268-73. PubMed ID: 15537997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrathecal baclofen for treatment of intractable spinal spasticity.
    Abel NA; Smith RA
    Arch Phys Med Rehabil; 1994 Jan; 75(1):54-8. PubMed ID: 8291963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness modeling of intrathecal baclofen therapy versus other interventions for disabling spasticity.
    Bensmail D; Ward AB; Wissel J; Motta F; Saltuari L; Lissens J; Cros S; Beresniak A
    Neurorehabil Neural Repair; 2009; 23(6):546-52. PubMed ID: 19228818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic ultrasound in the treatment of ankle plantarflexor spasticity in a unilateral stroke population: a randomized, single-blind, placebo-controlled trial.
    Ansari NN; Naghdi S; Bagheri H; Ghassabi H
    Electromyogr Clin Neurophysiol; 2007; 47(3):137-43. PubMed ID: 17557646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of spasticity with botulinum toxin].
    Kerty E; Stien R
    Tidsskr Nor Laegeforen; 1997 May; 117(14):2022-4. PubMed ID: 9235678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of a pulsed electromagnetic therapy on multiple sclerosis fatigue and quality of life: a double-blind, placebo controlled trial.
    Lappin MS; Lawrie FW; Richards TL; Kramer ED
    Altern Ther Health Med; 2003; 9(4):38-48. PubMed ID: 12868251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pilot study of a comparison between a patient scored numeric rating scale and clinician scored measures of spasticity in multiple sclerosis.
    Anwar K; Barnes MP
    NeuroRehabilitation; 2009; 24(4):333-40. PubMed ID: 19597271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of transcutaneous electrical nerve stimulation (TENS) on spasticity in multiple sclerosis.
    Miller L; Mattison P; Paul L; Wood L
    Mult Scler; 2007 May; 13(4):527-33. PubMed ID: 17463075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A clinical study of intrathecal baclofen using a programmable pump for intractable spasticity.
    Guillaume D; Van Havenbergh A; Vloeberghs M; Vidal J; Roeste G
    Arch Phys Med Rehabil; 2005 Nov; 86(11):2165-71. PubMed ID: 16271565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effect of baclofen and transcutaneous electrical nerve stimulation for the treatment of spasticity in multiple sclerosis.
    Shaygannejad V; Janghorbani M; Vaezi A; Haghighi S; Golabchi K; Heshmatipour M
    Neurol Res; 2013 Jul; 35(6):636-41. PubMed ID: 23582109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tizanidine treatment of spasticity caused by multiple sclerosis: results of a double-blind, placebo-controlled trial. US Tizanidine Study Group.
    Smith C; Birnbaum G; Carter JL; Greenstein J; Lublin FD
    Neurology; 1994 Nov; 44(11 Suppl 9):S34-42; discussion S42-3. PubMed ID: 7970009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of intrathecal baclofen on sleep and respiratory function in patients with spasticity.
    Bensmail D; Quera Salva MA; Roche N; Benyahia S; Bohic M; Denys P; Bussel B; Lofaso F
    Neurology; 2006 Oct; 67(8):1432-6. PubMed ID: 17060570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of acute unloaded leg cycling on spasticity in individuals with multiple sclerosis using anti-spastic medications.
    Motl RW; Snook EM; Hinkle ML
    Int J Neurosci; 2007 Jul; 117(7):895-901. PubMed ID: 17613103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.